A candidate vaccine against SARS-CoV-2 that uses the yellow fever 17D live-virus vector is highly efficacious and displays a favourable safety profile in Syrian hamster, mouse and cynomolgus macaque models.
- Lorena Sanchez-Felipe
- Thomas Vercruysse
- Kai Dallmeier